NASDAQ : IART

Integra LifeSciences Holdings Corporation — News

$17.25 USD

$0.15 (0.88%)

Volume
623.76K
Average Volume
1.02M
Market Capitalization
$1.34B
P/E Ratio
-187.09
Dividend Yield
0.00%
Price Target
$19.00
Year High
$20.49
Year Low
$8.70
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.40
Source Headline
Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-08-05 10:51:07

Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript

seekingalpha.com - 2026-07-29 19:33:26

3 Stocks Showing Breakout Potential Ahead of August

Breakout stocks BSET, AVAH and IART are trading near 52-week highs after passing technical screens. See why they could outperform in August.

zacks.com - 2026-07-29 16:01:05

Integra (IART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-07-29 11:31:10

Integra LifeSciences Q2 Earnings Call Highlights

Integra LifeSciences NASDAQ: IART reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and operational execution supported results. Adjusted earnings per share rose 24% year over year to $0.56, exceeding the company's guidance range.

marketbeat.com - 2026-07-29 11:07:44

Integra LifeSciences (IART) Q2 Earnings Top Estimates

Integra LifeSciences (IART) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago.

zacks.com - 2026-07-29 08:31:22

Integra LifeSciences Reports Second Quarter 2026 Financial Results

PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2026.

globenewswire.com - 2026-07-29 06:00:00

Here's Why Integra LifeSciences (IART) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-07-28 10:41:18

Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm

Investor litigation firm [url="]Kaskela Law[/url] announces that it is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) (“Integra”) on beha

gurufocus.com - 2026-07-23 08:00:00

Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) (“Integra”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/cases/integra-lifesciences/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company's stock between March 11, 2019 and May 22, 2023 (the “Wrongdoing Period”.

businesswire.com - 2026-07-23 07:00:00

IART vs. SONVY: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-07-22 12:41:09

Integra LifeSciences Holdings Corporation (IART) Soars to 52-Week High, Time to Cash Out?

Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.com - 2026-07-16 10:36:46

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open.

globenewswire.com - 2026-07-16 08:00:00

IART Stock Surges 52.1% in a Year: What's Driving the Rally?

Integra LifeSciences has climbed 52.1% in a year as growth across both segments, improved execution and transformation efforts continue to boost results.

zacks.com - 2026-07-15 13:05:20

Here's Why Integra LifeSciences (IART) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-07-09 10:41:37

Integra (IART) Is Attractively Priced Despite Fast-paced Momentum

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

zacks.com - 2026-07-09 09:56:51

IART or SONVY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-07-06 12:40:33

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Kirlew will lead Integra's global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution. Kirlew will lead Integra's global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution.

globenewswire.com - 2026-07-02 08:30:00

Integra Lifesciences Holdings Corp (IART) Shares Fall 4.2% -- What GF Score of 71 Tells Investors

On June 30, 2026, Integra Lifesciences Holdings Corp (IART) shares fell 4.2% to $17.98, amid a 52-week trading range of $8.70 to $18.92. This decline comes desp

gurufocus.com - 2026-06-30 21:27:00

Bet on These 3 Stocks as Broker Rating Upgrades Signal Upside

MITT, SVM and IART stand out as broker rating upgrades, earnings growth forecasts and screen criteria point to potential upside.

zacks.com - 2026-06-23 09:36:08

Integra LifeSciences Announces Key Executive Appointments

PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Corporation Holdings (Nasdaq: IART), a global leader in medical technology, today announced several leadership appointments within its commercial organization.

globenewswire.com - 2026-06-23 08:00:00

Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-06-22 10:56:22

Integra (IART) Shows Fast-paced Momentum But Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

zacks.com - 2026-06-22 09:55:52

Integra LifeSciences: New Beginning

Integra LifeSciences specializes in neuro-related surgical devices and regenerative tissue technologies. The tissue reconstruction segment, featuring collagen-based products like Integra Skin and PriMatrix, is positioned as IART's primary future earnings driver. IART suffered significant earnings declines and a 75% share price drop due to FDA-related product recalls and operational lapses at its Boston facility.

seekingalpha.com - 2026-06-22 01:37:29

IART vs. SONVY: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-06-19 12:41:03

Integra LifeSciences Holdings Corporation (IART) Hits Fresh High: Is There Still Room to Run?

Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.com - 2026-06-16 10:15:36

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.

globenewswire.com - 2026-06-15 08:30:00

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

PRINCETON, N. J. , June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.

globenewswire.com - 2026-06-15 08:30:00

Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-09 10:41:19

Why Is Integra (IART) Up 15% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-04 12:36:31

IART vs. MASI: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Masimo (MASI). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com - 2026-06-03 12:41:08

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026 at 10:30am ET.

globenewswire.com - 2026-06-02 07:30:00

Integra LifeSciences Holdings Corporation (IART) Hit a 52 Week High, Can the Run Continue?

Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.com - 2026-05-29 10:16:12

4 High-Growth GARP Stocks With Attractive PEG Ratios for 2026

These four GARP stocks combine discounted PEG ratios with strong growth potential, offering investors a balanced strategy for 2026.

zacks.com - 2026-05-22 16:01:10

Integra LifeSciences (IART) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-05-22 10:41:16

IART or MASI: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or Masimo (MASI). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com - 2026-05-18 12:41:19

Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-05-18 10:50:22

Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears

Integra LifeSciences NASDAQ: IART is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer Lea Knight said during a Bank of America med tech conference discussion hosted by analyst Rei Tan.

marketbeat.com - 2026-05-17 18:03:41

Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-12 21:50:50

Get IART Insider Trade Alerts

IART Price Target Summary

Last Month

$19.00

2 analysts

Last Quarter

$20.50

4 analysts

Last Year

$18.17

6 analysts

All Time

$34.79

19 analysts

IART Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-30 Wells Fargo Maintain Equal Weight Equal Weight
2026-07-16 Truist Securities Maintain Hold Hold
2026-07-08 Citigroup Maintain Neutral Neutral
2026-05-28 Citigroup Upgrade Sell Neutral
2026-05-06 Wells Fargo Maintain Equal Weight Equal Weight
2026-05-06 Citigroup Maintain Sell Sell
2026-04-15 Truist Securities Maintain Hold Hold
2026-04-15 Argus Research Downgrade Buy Hold
2026-03-11 Citigroup Maintain Sell Sell
2026-02-27 Wells Fargo Maintain Equal Weight Equal Weight